{
    "id": 27602,
    "fullName": "CA9 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CA9 over exp indicates an over expression of the Ca9 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 768,
        "geneSymbol": "CA9",
        "terms": [
            "CA9",
            "CAIX",
            "MN"
        ]
    },
    "variant": "over exp",
    "createDate": "03/29/2018",
    "updateDate": "03/29/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13498,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SLC-0111, in combination with Telmozolomide, decreased cell proliferation of GBM cultured cells overexpressing Ca9 and increased survival of GBM patient-derived xenograft (PDX) models (PMID: 29263302).",
            "molecularProfile": {
                "id": 29148,
                "profileName": "CA9 over exp"
            },
            "therapy": {
                "id": 6827,
                "therapyName": "SLC-0111 + Temozolomide",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 11104,
                    "pubMedId": 29263302,
                    "title": "Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29263302"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29148,
            "profileName": "CA9 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}